Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3142 (miR-3142; hsa-mir-3142) is a short, non-coding RNA molecule involved in post-transcriptional regulation of gene expression, primarily by mediating mRNA destabilization or translational inhibition. miR-3142 has been implicated in oncogenesis and chemoresistance, particularly via downregulation of the tumor suppressor PTEN, resulting in activation of the PI3K/Akt signaling pathway. This microRNA has been proposed as a non-invasive serum biomarker for the detection and prognosis of cancers such as cervical cancer and plays roles in promoting cell proliferation, suppressing apoptosis, and mediating chemotherapy resistance in leukemia cell models[1][2][3].
Modulation of gene expression (mainly inhibition of PTEN leading to activation of PI3K/Akt pathway); indirect modulation of apoptosis and cell proliferation-related pathways
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3142 (miR-3142).